Full Breakdown
Intermittent Fasting Shows Promise in Managing Crohn’s Disease Symptoms
2/13/2026, 1:12:47 AM
Study Overview and Findings
Recent research from the University of Calgary has revealed that intermittent fasting, specifically time-restricted feeding within an eight-hour window, can significantly alleviate symptoms of Crohn’s disease. Crohn's disease is a chronic inflammatory condition affecting the gastrointestinal tract, characterized by symptoms such as diarrhea, abdominal pain, and fatigue. The clinical trial, funded by the Crohn’s & Colitis Foundation, involved 35 adults with Crohn’s disease who were either overweight or living with obesity. Participants were divided into two groups: one group followed an intermittent fasting schedule, while the other maintained their regular diet.
The results indicated that those practicing time-restricted feeding experienced a 40% reduction in disease activity and a 50% decrease in abdominal discomfort over a 12-week period. Additionally, participants in the fasting group lost an average of 5.5 pounds, contrasting with a 3.7-pound gain in the control group. Blood tests demonstrated significant improvements in inflammation and immune function, suggesting that meal timing may be crucial for digestive health.
Implications for Patient Care
Maitreyi Raman, MD, the study’s senior author, emphasized that the benefits of intermittent fasting extend beyond weight loss. She noted, “We saw meaningful improvements in disease symptoms, reduced abdominal discomfort, favorable shifts in metabolism and inflammation, and promising changes in gut bacteria.” This indicates that intermittent fasting could potentially help patients achieve lasting remission from Crohn's disease.
Andres Lorenzo Hurtado, senior vice president of translational research at the Crohn's & Colitis Foundation, remarked on the potential of time-restricted feeding, stating, “This research suggests that changing when we eat - not just what we eat - can improve metabolism, help the immune system work better, and support long-term remission from Crohn's disease.”
Criticism and Future Research
Despite the promising results, researchers caution that further studies are necessary to assess the long-term safety and effectiveness of time-restricted feeding for a wider population of individuals with inflammatory bowel disease (IBD). Natasha Haskey, a research associate at the University of British Columbia and lead investigator of the study, highlighted the need for practical tools for patients, noting that “time-restricted eating may be a sustainable option grounded in biology, offering patients more ways to manage their own wellness.”
Conclusion
The findings from this study suggest that intermittent fasting could serve as a viable strategy for managing Crohn’s disease symptoms, offering additional benefits beyond traditional dietary approaches. However, as the research progresses, it will be essential to conduct larger trials to confirm these results and explore the broader implications for individuals living with IBD.
